Calcium Gluconate
Product Images NDC 75834-171

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Calcium Gluconate (NDC 75834-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 10ml.jpg (Carton)

Carton 10ml.jpg (Carton)
NDC 75834-171-19 is a sterile Calcium Gluconate solution for intravenous use that comes in a 10 mL single-dose vial. Each mL contains Calcium gluconate, calcium saccharate, and water for injection. The pH of the solution may have been adjusted with Hydrochloric acid and/or sodium hydroxide. The solution contains no more than 400 mcg/L of aluminum and is free of preservatives. This solution is manufactured for Nivagen Pharmaceuticals, Inc., and must be stored at 20° to 25°C (68° to 77°F) (see USP Controlled Room Temperature). Unused portions of the solution must be discarded and not frozen. The container closure is not made with natural rubber latex. For proper usage, refer to the package insert, and use the solution only if it is clear and the seal is intact. If the solution is supersaturated, it may be prone to precipitation. More details are provided in the insert. If you need assistance or have any questions, you may call the toll-free number 1-877-977-0687.*
FDA Label Image

Vial 10ml.jpg (Label)

Vial 10ml.jpg (Label)
This is a description of Calcium Gluconate for injection, which contains 94 mg of calcium gluconate per mL. Each vial is a single dose of 10 mL and does not contain any preservatives. The injection may contain hydrochloric acid and/or sodium hydroxide to adjust pH. The manufacturer is Nivagen Pharmaceuticals, Inc. and the product has a manufacturing license number of 215. The solution has a concentration of 0.465 mEg/mL and 0.276 mOsmol/mL. The product should be used intravenously and the package insert should be consulted for proper dosage. Supersaturated solutions can result in precipitation, so caution is advised. Unused portions should be discarded and the product should not be frozen. The expiration date and batch number are included, but the text did not provide information on this.*
FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.